Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Breast (Late Stage^), 2017-2021

All Races (includes Hispanic), Female, All Ages

Sorted by Rate

State
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Percent of Cases with Late Stage
 sort by percent late descending
US (SEER+NPCR) 1 42.0 (41.9, 42.2) N/A 80,548 31.2
Puerto Rico 6 34.4 (33.2, 35.6) N/A 714 33.2
Arizona 6 37.0 (36.1, 37.9) 49 (46, 50) 1,548 29.7
Vermont 6 37.3 (34.5, 40.3) 48 (27, 50) 153 27.1
Rhode Island 6 38.4 (36.2, 40.7) 47 (27, 50) 260 26.0
Nevada 6 39.1 (37.8, 40.5) 46 (31, 49) 689 33.5
New Mexico 3 39.4 (37.7, 41.0) 45 (26, 49) 498 32.1
South Dakota 6 39.6 (37.0, 42.3) 44 (14, 49) 198 29.5
Alabama 6 39.8 (38.8, 40.8) 43 (30, 48) 1,239 31.1
Arkansas 6 39.8 (38.5, 41.2) 42 (25, 48) 721 30.8
Maine 6 40.1 (38.1, 42.1) 41 (16, 48) 372 28.3
Oregon 6 40.2 (39.1, 41.4) 40 (25, 47) 1,032 29.1
Texas 3 40.3 (39.9, 40.8) 39 (32, 45) 6,100 32.7
Alaska 6 40.4 (37.4, 43.6) 38 (6, 49) 146 31.5
New Hampshire 6 40.5 (38.5, 42.5) 37 (14, 48) 357 27.6
Michigan 6 40.7 (40.0, 41.5) 36 (26, 44) 2,504 30.6
New York 3 40.9 (40.4, 41.4) 35 (27, 42) 5,026 29.4
Tennessee 6 41.1 (40.2, 42.0) 34 (20, 43) 1,721 31.6
Virginia 6 41.3 (40.4, 42.1) 33 (20, 42) 2,110 30.9
North Dakota 6 41.3 (38.4, 44.3) 32 (4, 49) 168 30.2
Connecticut 3 41.4 (40.1, 42.6) 31 (14, 44) 939 27.7
Hawaii 3 41.5 (39.5, 43.6) 30 (7, 47) 363 28.3
Utah 3 41.6 (40.2, 43.2) 29 (11, 44) 605 34.5
California 3 41.8 (41.4, 42.2) 28 (20, 34) 9,240 32.7
Kansas 6 41.8 (40.4, 43.3) 27 (10, 43) 703 29.8
Pennsylvania 6 41.9 (41.2, 42.6) 26 (17, 36) 3,451 30.4
Minnesota 6 41.9 (40.9, 43.0) 25 (13, 39) 1,363 28.5
Kentucky 3 42.0 (40.8, 43.1) 24 (12, 40) 1,152 31.4
Wyoming 6 42.2 (38.9, 45.7) 23 (2, 48) 138 32.7
Wisconsin 6 42.5 (41.5, 43.5) 22 (10, 35) 1,491 29.5
Florida 6 42.5 (42.0, 43.1) 21 (13, 29) 5,952 31.4
Montana 6 42.7 (40.3, 45.2) 20 (3, 45) 276 29.5
Nebraska 6 42.7 (40.9, 44.6) 19 (4, 42) 464 31.4
Iowa 3 42.7 (41.3, 44.1) 18 (6, 37) 806 29.9
West Virginia 6 42.9 (41.2, 44.8) 17 (4, 40) 507 32.4
Colorado 6 43.0 (41.9, 44.0) 16 (7, 32) 1,359 31.3
New Jersey 3 43.1 (42.3, 43.9) 15 (8, 27) 2,455 30.6
Oklahoma 6 43.2 (42.0, 44.5) 14 (6, 32) 982 33.4
Missouri 6 43.7 (42.7, 44.7) 13 (5, 24) 1,630 31.5
Washington 5 43.8 (42.9, 44.7) 12 (5, 23) 1,899 30.6
Delaware 6 43.9 (41.5, 46.5) 11 (1, 41) 276 29.5
Ohio 6 44.2 (43.5, 44.9) 10 (5, 18) 3,227 32.0
South Carolina 6 44.2 (43.2, 45.3) 9 (4, 21) 1,406 31.4
Maryland 6 44.4 (43.4, 45.4) 8 (4, 19) 1,668 31.7
Illinois 3 44.5 (43.8, 45.2) 7 (4, 16) 3,402 32.3
Idaho 3 44.9 (43.0, 46.9) 6 (1, 25) 445 32.0
North Carolina 6 45.4 (44.6, 46.1) 5 (2, 11) 2,859 30.3
Mississippi 6 45.8 (44.4, 47.3) 4 (1, 13) 827 35.8
Louisiana 3 46.8 (45.6, 48.0) 3 (1, 7) 1,291 34.8
Georgia 3 47.0 (46.2, 47.7) 2 (1, 5) 2,885 34.6
District of Columbia 6 48.1 (44.8, 51.5) 1 (1, 19) 170 33.9
Indiana 6
data not available
N/A
data not available
data not available
Notes:
Created by statecancerprofiles.cancer.gov on 12/03/2024 3:59 am.

State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

Data not available for this combination of data selections.
1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2023 submission.
3 Source: SEER November 2023 submission. State Cancer Registry also receives funding from CDC's National Program of Cancer Registries.
5 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2023 submission.
6 Source: National Program of Cancer Registries SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2023 submission).

Data for the United States does not include data from Indiana.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top